Injective (INJ) is currently priced at $3.17, reflecting a 24-hour change of 1.32%. The daily trading range has been tight, with a low of $3.10 and a high of $3.22, indicating a relatively stable market in the short term.

Volume stands at approximately $35.14 million, contributing to a volume-to-market cap ratio of 11.08%. This level of trading activity suggests moderate interest from traders, which may support the current price level.

The moving averages reveal mixed signals; the 8 SMA and 13 SMA are trending upwards, indicating short-term bullish momentum, while the 55 SMA shows a decline, hinting at potential weakness in the longer term. The 144 SMA is also positive, but the overall trend appears to be consolidating as it hovers around the $3.19 level.

Momentum indicators show a 1-hour RSI at 54, suggesting neutral conditions, while the 7-day RSI at 52 indicates a lack of strong momentum either way. Notably, the price has decreased by 0.11% over the past week and has seen significant declines of 13.74% and 40.76% over the last 14 and 30 days, respectively, highlighting a bearish trend in the medium to long term.

With the all-time high of $52.62 occurring on March 14, 2024, the current price reflects a dramatic decrease from historical levels. This suggests that while there may be short-term trading opportunities, the overarching trend remains negative.

Given the current price action, mixed moving averages, and declining RSI over longer periods, I assign a Sell rating for Injective (INJ). The bearish momentum observed over the last month and a lack of solid upward movement signal that it may be prudent to exit positions or avoid new entries at this time.